These include acute lymphoblastic T-cell leukemia (T-ALL) (RPL10 and RPL5); glioma, melanoma, and breast cancer (RPL5); colorectal and endometrial cancer (RPL22); and chronic lymphocytic leukemia (RPS15) (31–34). This evidence concerns the gene RPL5 and acute lymphoblastic leukemia.